The Procter & Gamble Company Earnings Call Transcripts
Fiscal Year 2027
-
Organic sales rose 4.0% with growth across all categories and regions, while core EPS reached $2. FY27 guidance was maintained despite rising cost pressures, with H1 growth expected near 3% and a slight H2 acceleration.
Fiscal Year 2026
-
FY2026 delivered organic sales growth above 1%, core EPS growth of 1% and over $15B returned to shareholders. The Board’s nominees and management proposals passed, while all three shareholder proposals failed; priorities include consumer-led execution, innovation and adapting to market pressures.
-
Leadership highlighted a continued focus on execution and technology to drive growth, with no major changes to the core strategy. Key initiatives include automation, AI-driven R&D, and targeted interventions by market and category, with visible impacts expected within 12–24 months.
-
Fiscal 2026 met guidance with broad-based organic sales and EPS growth despite cost headwinds. Strategic interventions and innovation drove user growth, especially in China and Latin America, while guidance for fiscal 2027 anticipates continued volatility but targets modest sales and EPS growth.
-
The event highlighted a robust digital transformation strategy, leveraging unified data and AI to drive brand building, supply chain modernization, and rapid innovation. Real-time analytics, influencer management, and internalized creative functions are delivering efficiency and competitive advantage.
-
Achieved steady sales and earnings growth despite external pressures, maintaining FY2026 guidance. Strategic restructuring, innovation, and technology adoption are driving efficiency and market share gains, with strong momentum in most regions and a focus on restoring U.S. growth.
-
Q3 FY2026 saw broad-based organic sales growth and a 3% rise in core EPS, despite margin pressures from higher costs and increased investments. Guidance for the year is maintained, but full-year EPS is expected at the lower end of the range due to $1B in after-tax headwinds.
-
The conference detailed recent performance, strategic interventions, and digital transformation efforts, highlighting strong results from consumer-driven innovation and AI-enabled processes. Ongoing organizational changes and investments are expected to drive sequential improvement and position the company for future industry leadership.
-
Organic sales grew 3% in Q2 FY26, led by strong international performance, while U.S. sales declined due to inventory headwinds. FY26 guidance is unchanged, with expectations for stronger growth in the second half, driven by innovation and improved execution.
-
Organic sales grew 2% year-over-year, led by skin and personal care, with core EPS up 3%. Restructuring and innovation are driving agility and investment, while guidance for fiscal 2026 remains unchanged amid competitive and macroeconomic challenges.
Fiscal Year 2025
-
U.S. and Western Europe face volatility and muted growth, while China and Latin America show strong momentum. Innovation, restructuring, and AI adoption are central to driving future growth, with a focus on core brands and consumer insights. M&A will be selective and strategic.
-
The meeting covered strong financial results, board transitions, and a continued focus on sustainability and strategic growth. All board and management proposals passed, while a shareholder proposal on flexible plastic packaging reporting was rejected. Dividend increases and ESG progress were highlighted.
-
Global market growth is stable but below historical averages, with innovation and integrated superiority prioritized to drive future gains. Organizational redesign and supply chain automation are underway to boost agility and productivity, while the portfolio and leadership strategy remain focused on sustainable, innovation-led growth.
-
Organic sales and EPS grew in fiscal 2025 despite macro headwinds, with broad-based category and regional gains and strong cash returns to shareholders. Fiscal 2026 guidance anticipates continued volatility, with restructuring, tariffs, and innovation as key themes.
-
Management outlined consistent sales and earnings growth, a new two-year restructuring program, and ongoing productivity initiatives to address market volatility and unlock $20B-$25B in growth opportunities. Innovation, portfolio focus, and digital transformation remain central to the strategy.
-
Organic sales grew 1% amid consumer and retailer volatility, with strong innovation and market share resilience. Fiscal year guidance calls for 2% organic sales growth and 2%-4% core EPS growth, while tariff and cost headwinds remain key risks.
-
The conference highlighted strong multi-year growth, robust innovation, and disciplined strategy execution amid ongoing global volatility. Key innovations and digital advancements are driving category leadership, while financial guidance remains focused on long-term balanced growth.
-
Organic sales grew 3% with broad-based category gains and strong North America and Europe performance. Core EPS rose 2% to $1.88, and guidance for fiscal 2025 remains unchanged despite FX and commodity headwinds. Innovation and productivity are expected to drive results in the second half.
-
Earnings and cash results were solid, with 2% organic sales growth and strong performance in 85% of the business, offset by continued volatility in China and the Middle East. Guidance for FY25 remains unchanged, with a focus on innovation and productivity to drive growth.
Fiscal Year 2024
-
Management outlined strong growth opportunities in core categories, driven by innovation, productivity, and superior consumer value. Despite regional volatility and short-term operational challenges, sequential sales and share gains are expected, supported by technology and targeted marketing.
-
A dynamic, integrated strategy focused on superiority, productivity, and innovation is driving balanced growth, margin expansion, and strong cash returns. Significant opportunities remain in North America, Europe, and enterprise markets, with robust investment in R&D, supply chain, and digital capabilities supporting future growth.
-
The meeting covered strong financial results, board elections, and a failed shareholder proposal on pay gap reporting. A quarterly dividend was announced, and strategic priorities were reaffirmed amid ongoing market and geopolitical challenges.
-
Delivered strong annual results despite external headwinds, with 85% of the business normalizing to 3%-4% growth. China remains soft but stable, while innovation and productivity initiatives continue to drive long-term strategy and margin expansion.
-
Fiscal 2024 saw strong organic sales and EPS growth, with robust cash returns to shareholders and record gross margins, despite headwinds in China and select markets. Fiscal 2025 guidance anticipates continued volatility but projects 3%-5% organic sales growth and 5%-7% EPS growth.
-
The conference highlighted strong multi-year growth, robust productivity gains, and strategic focus on product superiority and supply chain innovation. Resilient consumer demand in key markets and targeted innovation in challenged regions underpin a cautiously optimistic outlook for 2025.